Fig. 1From: Impact of anemia treatment for left ventricular hypertrophy using long-acting erythropoietin-stimulating agents from the pre-dialysis to maintenance dialysis period in patients with chronic kidney disease, retrospective longitudinal cohort studyPatient disposition and flow chart showing patient selection criteria. LVMI Left ventricular mass index, ESA Erythropoietin-stimulating agents, Hb Hemoglobin, G1, Group 1; G2, Group 2; Group 3 Back to article page